Rallybio Corporation (RLYB)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20264 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Rallybio Corporation’s names, not what it holds today.
4 published
3 published
0 published
0 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Sep 10, 2024 | 12,083,160 | Polypeptides binding to human complement C5 | Pharmaceuticals | IPC Research, LLC |
| Aug 15, 2023 | 11,725,063 | Antibodies against HPA-1a | Biotechnology | Rallybio IPA, LLC |
| Sep 21, 2021 | 11,123,401 | Polypeptides binding to human complement C5 | Pharmaceuticals | IPC Research, LLC |
| Jan 5, 2021 | 10,882,919 | Antibodies against HPA-1a | Biotechnology | Rallybio IPA, LLC |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Oct 30, 2025 | 2025/0332214 | POLYPEPTIDES BINDING TO HUMAN COMPLEMENT C5 | Pharmaceuticals | IPC Research, LLC |
| Jan 2, 2025 | 2025/0003985 | Assays for Quantification of Anti-HPA-1a Antibodies | Analysis of biological materials | Rallybio IPA, LLC |
| Dec 26, 2024 | 2024/0424055 | ADMINISTRATION OF C5-BINDING PROTEINS | Pharmaceuticals | IPC Research, LLC |
| May 2, 2024 | 2024/0141067 | Administration of Anti-HPA-1a Antibodies | Pharmaceuticals | Rallybio IPA, LLC |
| May 2, 2024 | 2024/0141066 | Method of Administering Anti-HPA-1a Monoclonal Antibody | Pharmaceuticals | Rallybio IPA, LLC |
| Dec 30, 2021 | 2021/0401930 | POLYPEPTIDES BINDING TO HUMAN COMPLEMENT C5 | Pharmaceuticals | IPC Research, LLC · patent 12,083,160 granted from it |
| Jun 24, 2021 | 2021/0189005 | Antibodies Against HPA-1a | Biotechnology | Rallybio IPA, LLC · patent 11,725,063 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.